RT @RHEUMarampa: IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurr
Tweet Content
IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurrences
Potential therapeutic targets to ⬇GC toxicity
✏B cell/plasmablasts (promising)
✏T cells (anecdotal)
@RheumNow #ACR20 https://t.co/X2NI3vFUgl
Show on Archive Page
On
Display in Search Results
On